当前位置: X-MOL 学术Mol. Ther. Methods Clin. Dev. › 论文详情
Chromosome transplantation: a possible approach to treat human X-linked disorders.
Molecular Therapy - Methods & Clinical Development ( IF 4.875 ) Pub Date : 2020-01-21 , DOI: 10.1016/j.omtm.2020.01.003
Marianna Paulis; Lucia Susani; Alessandra Castelli; Teruhiko Suzuki; Takahiko Hara; Letizia Straniero; Stefano Duga; Dario Strina; Stefano Mantero; Elena Caldana; Lucia Sergi Sergi; Anna Villa; Paolo Vezzoni

Many human genetic diseases are associated to gross mutations such as aneuploidies, deletions, duplications or inversions. For these “structural” disorders conventional gene therapy, based on viral vectors and/or on programmable nuclease-mediated homologous recombination, is still unsatisfactory. To correct this type of disorders, Chromosome Transplantation (CT), defined as the perfect substitution of an endogenous defective chromosome with an exogenous normal one, could be applied. CT re-establishes a normal diploid cell, leaving no marker of the procedure, as we have recently shown in mouse pluripotent stem cells. To prove the feasibility of the CT approach in human cells we used induced pluripotent stem cells (hiPSCs) reprogrammed from the Lesch-Nyhan (LN) disease patients, taking advantage of their mutation in the X-linked HPRT gene, making the LN cells selectable and distinguishable from the resistant corrected normal cells. Here we demonstrate, for the first time, that CT is feasible in hiPSCs: normal exogenous X chromosome was first transferred using an improved chromosome transfer system and the extra sex chromosome was spontaneously lost. These CT cells were functionally corrected and maintained their pluripotency and differentiation capability. By inactivation of the autologous HPRT gene, CT paves the way to the correction of hiPSCs from several X-linked disorders.
更新日期:2020-01-21

 

全部期刊列表>>
化学/材料学中国作者研究精选
ACS材料视界
南京大学
自然科研论文编辑服务
剑桥大学-
中国科学院大学化学科学学院
南开大学化学院周其林
课题组网站
X-MOL
北京大学分子工程苏南研究院
华东师范大学分子机器及功能材料
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug